EARLY SERUM HEPATITIS B VIRUS LARGE SURFACE PROTEIN LEVEL: A STRONG PREDICTOR OF VIROLOGICAL RESPONSE FOR PEGINTERFERON, BUT NOT FOR ENTECAVIR, IN HBeAg-POSITIVE CHRONIC HEPATITIS B

被引：0
作者：
Zhu, X. J. [1 ]
Gong, Q. M. [1 ]
Yu, D. M. [1 ]
Zhang, D. H. [1 ]
Gu, L. L. [1 ]
Han, Y. [1 ]
Chen, J. [1 ]
Zhang, X. X. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Dept Infect Dis, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60785-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
783
引用
收藏
页码：S319 / S319
页数：1
相关论文
共 50 条
  • [21] Response-guided peginterferon therapy for hbeag-positive and hbeag-negative chronic hepatitis b using hepatitis b surface antigen levels: A review
    Sonneveld M.J.
    Brouwer W.P.
    Janssen H.L.A.
    Current Hepatology Reports, 2014, 13 (3) : 250 - 255
  • [22] HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
    Fried, Michael W.
    Piratvisuth, Teerha
    Lau, George K. K.
    Marcellin, Patrick
    Chow, Wan-Cheng
    Cooksley, Graham
    Luo, Kang-Xian
    Paik, Seung Woon
    Liaw, Yun-Fan
    Button, Peter
    Popescu, Matei
    HEPATOLOGY, 2008, 47 (02) : 428 - 434
  • [23] Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B
    Sonneveld, Milan J.
    Arends, Pauline
    Boonstra, Andre
    Hansen, Bettina E.
    Janssen, Harry L. A.
    JOURNAL OF HEPATOLOGY, 2013, 58 (05) : 898 - 903
  • [24] Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B
    Sherman, Morris
    Yurdaydin, Cihan
    Sollano, Jose
    Silva, Marcelo
    Liaw, Yun-Fan
    Cianciara, Janusz
    Boron-Kaczmarska, Anna
    Martin, Paul
    Goodman, Zachary
    Colonno, Richard
    Cross, Anne
    Denisky, Gail
    Kreter, Bruce
    Hindes, Robert
    GASTROENTEROLOGY, 2006, 130 (07) : 2039 - 2049
  • [25] Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients
    Bradshaw, D.
    Danta, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (09) : 992 - 992
  • [26] Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
    Peng, C. -Y.
    Lai, H. -C.
    Li, Y. -F.
    Su, W. -P.
    Chuang, P. -H.
    Kao, J. -T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (04) : 458 - 468
  • [27] Response-guided peginterferon therapy in HBeAg-positive chronic hepatitis B using serum hepatitis B surface antigen levels: a pooled analysis of 803 patients
    Sonneveld, Milan J.
    Hansen, Bettina E.
    Piraivisuth, Teerha
    Jia, Jidong
    Zeuzem, Stefan
    Gane, Edward J.
    Liaw, Yun-Fan
    Xie, Qing
    Heathcote, E. Jenny
    Chan, Henry Lik-Yuen
    Janssen, Harry L.
    HEPATOLOGY, 2012, 56 : 202A - 202A
  • [28] PREDICTION OF RESPONSE TO PEGINTERFERON FOR HBEAG-POSITIVE CHRONIC HEPATITIS B USING QUANTITATIVE SEROLOGY: HBEAG VERSUS HBSAG
    Sonneveld, M. J.
    Rijckborst, V.
    Hansen, B. E.
    Janssen, H. L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S215 - S216
  • [29] Effects of telbivudine and entecavir for HBeAg-positive chronic hepatitis B: A meta-analysis
    Su, Qi-Min
    Ye, Xiao-Guang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (43) : 6290 - 6301
  • [30] Effects of telbivudine and entecavir for HBeAg-positive chronic hepatitis B: A meta-analysis
    Qi-Min Su
    World Journal of Gastroenterology, 2012, (43) : 6290 - 6301
12345